Retender radar: UK public contracts ending soon
Every contract in the catalogue with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting, unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.
When contracts end · Medical equipments, pharmaceuticals i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
902 contracts end within 24 months, 1,006 in total · £854m published GBP value, exc. VAT, in the next 24 months (framework ceilings included, not a spend forecast).
By sector, next 24 months i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
CPV division of the procedure; a contract with several divisions counts in each.
85Health and social work services1,78560Transport services (except waste transport)1,16433Medical equipments, pharmaceuticals90279Business services: law, marketing, consulting63380Education and training services36790Sewage, refuse, cleaning and environmental28550Repair and maintenance services27545Construction work252
Contracts ending in the next 24 months
Showing 991–1,005
- Ends · in 625 days
Antiretroviral Drugs
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) · NHS & health · Wales (Cymru)
Incumbent: ViiV Healthcare
- Contract value
- £12m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac3a
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Camurus AB
- Contract value
- £11m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Biologic and Biosimilar Medicines
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Amgen Ltd
- Contract value
- £8.8m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-049b93
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: NOVARTIS PHARMACEUTICALS UK LIMITED
- Contract value
- £8.7m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Teva UK Ltd
- Contract value
- £6.6m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 daysExtension option · up to 30 Jun 2029Panel · 6 suppliers
Ustekinumab
Public Health Wales NHS Trust · Central government · Wales (Cymru)
Panel: Amgen Ltd, Celltrion Healthcare Uk Ltd, Fresenius Kabi Limited +3 more
- Contract value
- £6.5m
- Annual run-rate
- —panel, not one supplier
- Term
- 1 Oct 2026 → 30 Jun 2028 · 1.7 yrs · up to 30 Jun 2029 with extensions
- Reference
ocds-h6vhtk-05f601
- Ends · in 625 days
Biologic and Biosimilar Medicines
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Celltrion Healthcare United Kingdom Limited
- Contract value
- £6.5m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-049b93
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Chiesi Limited
- Contract value
- £6.4m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Glaxo Smithkline
- Contract value
- £6.1m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Biologic and Biosimilar Medicines
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Pfizer Ltd
- Contract value
- £5.7m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-049b93
- Ends · in 625 days
Aseptics Medicines (Including Cytotoxics)
Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts) · NHS & health · Nationwide (UK), Wales (Cymru)
Incumbent: Sanofi
- Contract value
- £4.8m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-0496e2
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Orion Pharma UK Ltd
- Contract value
- £4.8m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Otsuka Pharmaceuticals (UK) Ltd
- Contract value
- £4.7m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Proprietary Drugs
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Merz
- Contract value
- £4.2m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-04ac47
- Ends · in 625 days
Biologic and Biosimilar Medicines
eTenderwales · Nationwide (UK), Wales (Cymru)
Incumbent: Abbvie Ltd
- Contract value
- £4.1m
- Annual run-rate
- —start date not published
- Term
- Ends 30 Jun 2028 · start not published
- Reference
ocds-h6vhtk-049b93
How to read the radar
- End date is the contract period end the buyer published on the notice. Contracts without an end date are not on the radar.
- Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
- Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
- Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
- Counts are exact for the time-horizon and sector filters. With other filters, a result above 1,000 contracts shows as “1,000+”.
- Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.